Cost Reduction Icon
Using low-cost feedstocks (Ferulic Acid or Glucose) dramatically reduces the final cost compared to vanilla bean extraction.
Vanillin is the world's most widely used flavoring agent, essential in flavors, fragrances, and cosmetics. Only 1\% of the market is supplied by natural vanilla beans, which are environmentally sensitive and require labor-intensive processing, making Extraction from vanilla beans extremely costly due to limited raw material supply . The remaining 99\% is produced synthetically, but Petrochemical synthesis generates harmful by-products and is not considered " natural flavoring " by regulatory bodies, limiting its use in premium markets.
CD Biosynsis offers a comprehensive metabolic engineering and synthetic biology solution to produce "Natural Vanillin" biosynthetically. The core strategy is to Engineer biosynthetic pathways that utilize glucose or inexpensive substrates like lignin-derived Ferulic Acid . Ferulic Acid (FA) is preferred as it is structurally close to Vanillin and is an abundant byproduct of the pulp and paper industry. We then Metabolically engineer hosts (E. coli or C. glutamicum) with key enzymes to achieve efficient biological conversion of Ferulic Acid to Vanillin . This involves introducing and optimizing two main enzymes: Feruloyl-CoA Synthetase (Fcs) and Enoyl-CoA Hydratase/Lyase (Ech), which work together to perform the necessary side-chain shortening and cleavage reactions. This bio-conversion route provides a stable, low-cost, and regulatory-compliant natural Vanillin supply.
Get a QuoteIndustrial Vanillin production faces these key challenges:
A successful solution must provide a high-yield, low-cost route that meets "Natural" regulatory standards.
CD Biosynsis utilizes advanced metabolic engineering and synthetic biology to optimize Vanillin production:
Efficient Bio-Conversion of Ferulic Acid to Vanillin
We engineer hosts (E. coli, C. glutamicum) with the Feruloyl-CoA synthetase (Fcs) and Enoyl-CoA Hydratase (Ech) system to perform efficient side-chain shortening.
De Novo Pathway Engineering from Glucose
For Ferulic Acid-free production, we build the Vanillin pathway from Tyrosine/Shikimate precursors, including Tyrosine Ammonia Lyase (TAL) and hydroxylases , to use inexpensive glucose feedstock.
Block Side Product and Degradation Pathways
We perform gene knockouts (e.g., VanA}/\text{VanB genes) to prevent Vanillin degradation into Vanillic Acid and to eliminate unwanted side products.
Enhance Vanillin Tolerance and Recovery
We engineer the host for increased tolerance to toxic Vanillin and implement in situ product removal (ISPR) to continuously extract the product from the broth.
This systematic approach provides a high-yield, low-cost, and "Natural" compliant route for Vanillin production.
Our Vanillin engineering service is dedicated to pursuing the following production goals:
Cost Reduction Icon
Using low-cost feedstocks (Ferulic Acid or Glucose) dramatically reduces the final cost compared to vanilla bean extraction.
Natural Flavor Compliance Icon
Production via microbial fermentation allows the final product to be marketed as Natural Flavoring , opening access to premium markets.
High Titer and Purity Icon
Pathway optimization and degradation blocking ensures high final titer and minimal undesirable by-products.
Sustainable Production Icon
Utilizing lignin-derived Ferulic Acid converts an industrial waste stream into a valuable product, promoting circular economy.
Stable Supply Chain Icon
Microbial fermentation provides an industrial-scale solution independent of agricultural and geopolitical factors.
We provide a superior and sustainable manufacturing platform for Natural Vanillin .
Our Vanillin strain engineering service follows a rigorous, multi-stage research workflow:
Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and product quality attributes.
Explore the potential for a cost-effective, high-quality Natural Vanillin supply. CD Biosynsis provides customized strain and process engineering solutions:
Why is Vanillin from Ferulic Acid considered "Natural Flavoring"?
Regulatory bodies in the EU and US classify flavorings derived from natural raw materials (e.g., Ferulic Acid from rice bran or sugar beet pulp) via fermentation as Natural Flavoring. This is because the bio-conversion process is enzymatic and mimics natural plant metabolism, unlike synthesis from petrochemical guaiacol.
What is the role of Feruloyl-CoA Synthetase (Fcs) and Enoyl-CoA Hydratase (Ech) ?
This Fcs}/\text{Ech enzyme system is crucial for the beta-oxidation-like side-chain cleavage of Ferulic Acid. Fcs first activates Ferulic Acid by attaching CoA. Ech then performs hydration and cleavage to shorten the side chain and release the final Vanillin molecule.
How do you deal with Vanillin Toxicity ?
Since Vanillin is antimicrobial, accumulation inhibits cell growth and production. We address this with In Situ Product Removal (ISPR) , where adsorbents or organic solvents are added to the fermenter to continuously extract the Vanillin as it is produced. This keeps the extracellular concentration low, protecting the host and simultaneously simplifying final purification.
What is the benefit of blocking Vanillin degradation pathways ?
Many microbial hosts naturally possess enzymes (e.g., VanA}/\text{VanB) that oxidize Vanillin into Vanillic Acid. Vanillic Acid is an unwanted byproduct that reduces yield. Knockout of these degradation genes ensures the Vanillin product remains stable and at high concentration in the culture broth.
What is the estimated project timeline?
A project focusing on bio-conversion from Ferulic Acid, including enzyme optimization, gene knockouts, and ISPR development, typically requires 20-26 weeks for final industrial strain and process delivery.
CRISPR-Cas9 technology represents a transformative advancement in gene editing techniques. The main function of the system is to precisely cut DNA sequences by combining guide RNA (gRNA) with the Cas9 protein. This technology became a mainstream genome editing tool quickly after its 2012 introduction because of its efficient, simple and low-cost nature.
The CRISPR gene editing system with its Cas9 version stands as a vital instrument for current biological research. CRISPR technology enables gene knockout (KO) through permanent gene expression blockage achieved by sequence disruption. Various scientific domains including disease modeling and drug screening employ this technology to study gene functions. CRISPR KO technology demonstrates high efficiency and precision but requires confirmation and verification post-implementation because unsatisfactory editing may produce off-target effects or incomplete gene knockouts which impact experimental result reliability. For precise and efficient Gene Editing Services - CD Biosynsis, Biosynsis offers comprehensive solutions tailored to your research needs.
The CRISPR-Cas9 knockout cell line was developed using CRISPR/Cas9 gene editing to allow scientists to remove genes accurately for research on gene function and disease models and pharmaceutical discovery. Genetic research considers this technology essential due to its high efficiency together with simple operation and broad usability.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.